Healthcare Trust Of America, Inc. (NYSE:HTA) Valuation According To Analysts

The stock is now showing YTD performance of 5.36 Percent. Franklin Resources Inc stated it has 4.96M shares or 0.11% of all its holdings.

A number of other hedge funds also recently made changes to their positions in the company. Zacks Investment Research lowered shares of Healthcare Trust of America from a "hold" rating to a "sell" rating in a research report on Tuesday, December 27th. Mizuho has "Buy" rating and $32 target. Daiwa Securities Group Inc. now owns 10,382,397 shares of the real estate investment trust's stock valued at $322,997,000 after purchasing an additional 2,586,706 shares during the period. Additionally Healthcare Trust of America, In declared a dividend for shareholders payable on Friday October 6th, 2017.

Coliseum Capital Management Llc holds 60.83% of its portfolio in The Providence Service Corporation for 1.97 million shares. Public Employees Retirement Association of Colorado increased its stake in Healthcare Trust of America by 44.0% during the second quarter. Baird Financial Group, Inc. now controls 296,281 shares valued at $9,217,000. Finally, Comerica Bank bought a new stake in Healthcare Trust of America during the first quarter worth approximately $202,000. The company was maintained on Tuesday, July 4 by Stifel Nicolaus. Institutional investors and hedge funds own 97.75% of the company's stock. If you are accessing this piece on another publication, it was illegally stolen and reposted in violation of worldwide copyright legislation.

07/11/2017 - Healthcare Trust of America, Inc. had its "mkt perform" rating reiterated by analysts at FBR Capital Markets.

Healthcare Trust of America, Inc.is a real estate investment trust. With the last stock price close up 0.20% from the two hundred day average, compared with the S&P 500 Index which has increased 0.04% over the date range. The stock had a trading volume of 1,101,529 shares. The company has market cap of $6.15 billion. The firm's 50 day moving average price is $29.86 and its 200-day moving average price is $30.56. As per Thursday, December 31, the company rating was maintained by Stifel Nicolaus.

'Newton' is India's official entry to Oscars 2018
Newton is a film about a government employee who's sent to a Naxal-controlled region of Chhattisgarh to conduct fair elections. The music by Naren Chandavarkar and Benedict Taylor adds a subtle undertone to the sombre note of the narrative.

Healthcare Trust of America, Inc. on 6/29/2017 reported its EPS as $0.04 with the analysts projecting the EPS of the stock as $0.09. The real estate investment trust reported $0.39 EPS for the quarter, meeting the Thomson Reuters' consensus estimate of $0.39. Healthcare Trust of America had a return on equity of 1.42% and a net margin of 6.07%. They expect $0.35 earnings per share, 0.00% or $0.00 from last year's $0.35 per share.

Analysts are also projecting an Average Revenue Estimate for Healthcare Trust of America, Inc.as $155810 in the Current Quarter.

On a similar note, analysts expect EPS of $0.41 in September 2017 quarter and $0.42 in December 2017 quarter, representing 2.5% and 0% growth, respectively. Healthcare Trust of America's dividend payout ratio is presently 571.43%. Three equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. UBS AG raised Healthcare Trust of America from an "outperform" rating to a "strong-buy" rating in a research note on Monday, July 17th.

01/04/2016 - Oppenheimer began new coverage on Healthcare Trust of America, Inc. giving the company a "outperform" rating. Raymond James upgraded the stock to "Strong Buy" rating in Monday, July 17 report. Jefferies Group LLC raised Healthcare Trust of America to a "buy" rating and set a $36.00 price target on the stock in a report on Monday, June 5th. The company now has an average rating of "Buy" and a consensus target price of $34.14. The stock's last price was lower from the average trading price of 50 days recorded at $39.85 while enlarging the period to 200 trading days, the average price was $50.87. Following the completion of the transaction, the chief executive officer now directly owns 405,092 shares in the company, valued at $12,987,249.52. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. The portion of a company's profit allocated to each outstanding share of common stock was $3.45 a share in the trailing twelve months. The Massachusetts-based Eagle Boston Investment Management Inc has invested 1.18% in the stock. The Company is an owner and operator of medical office buildings (MOBs) in the United States.

Latest News